US.BDX · Becton Dickinson

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.131284916201117,
        "turnoverUsdM": 320.09496,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.BDX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 171.37,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.3,
      "take_profit_price": 187.95,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.262569832402234,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 50,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 47,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 182.006,
    "ma50": 179.1188,
    "close": 179,
    "prevClose": 181.97,
    "avgVolume20": 1823842,
    "volumeRatio": 0.98,
    "changePercent": -1.63
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.019285557747096282,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.9943422402504427,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8934560358335412,
      "volat_points": 0,
      "day_range_pct": 0.018826815642458125,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 50,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 17.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 57,
        "contribution": 17.1
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 47,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 6/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 17.1/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 6,
      "市場環境": 8.6,
      "情緒分析": 3,
      "技術信號": 17.1,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 320.09496,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BDX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.04
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 724.5444967999999,
                "ma50": 714.93099846,
                "name": "QQQ",
                "close": 739.77002,
                "points": 2
              },
              "spy": {
                "ma20": 765.0634969,
                "ma50": 762.7413972399996,
                "name": "SPY",
                "close": 762.63,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.131284916201117,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142469358,
                "url": "https://finnhub.io/api/news?id=df6606a47f06bf41c262e3c74d80e5e1a9270c0e6b943a74aeee5a7d769eac3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson's MedTech transformation, innovation pipeline and strategic partnerships support growth despite reimbursement and macroeconomic pressures.",
                "category": "company",
                "datetime": 1790608500,
                "headline": "Here's Why You Should Retain BDX Stock in Your Portfolio for Now"
              },
              {
                "id": 142286417,
                "url": "https://finnhub.io/api/news?id=5dd23fe5e9615e5e1fac99a81dbb5a829ca077e995eccd08c53bbbeafd528560",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (NYSE:BDX) reached an SEC cease and desist settlement over past Alaris infusion pump risk disclosures, including a civil penalty and creation of a Fair Fund for investors. Subsidiary C.R. Bard recently faced a plaintiff verdict in Bard PowerPort litigation, with thousands of related product liability cases still pending. The Alaris disclosure settlement and Bard PowerPort verdict both tie into a wider pattern of legal and compliance pressures our research tracks. We have...",
                "category": "company",
                "datetime": 1789898962,
                "headline": "Why Is Becton Dickinson (BDX) Facing Fresh SEC And Litigation Pressure?"
              },
              {
                "id": 142166116,
                "url": "https://finnhub.io/api/news?id=9d096852b479a00d578130a812ade2f1359c9aa90af267750b8fd8fcff2a960a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.",
                "category": "company",
                "datetime": 1789485660,
                "headline": "BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation"
              },
              {
                "id": 142027197,
                "url": "https://finnhub.io/api/news?id=7fd23c787c97bfe50fed26561c991b2395d3536d42df1fb0c06d8a96ee37815e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Becton, Dickinson and Company (BDX) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsThomas Polen - President,...",
                "category": "company",
                "datetime": 1788961637,
                "headline": "Becton, Dickinson and Company (BDX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141394944,
                "url": "https://finnhub.io/api/news?id=1f2d90bf76cdf9483bf09b320f85ea31b0881537420c526b48fe2815dd22eb5b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (NYSE:BDX) has become a founding sponsor of a new Medicinal Hazard Data Standardization Consortium focused on hazardous drug information. The global initiative aims to create standardized Medicinal Hazard Data Sheets to reduce data fragmentation and support safer handling of hazardous medicines for healthcare workers. Several major healthcare companies are joining BD in the consortium, which is expected to influence future regulatory and clinical best practice...",
                "category": "company",
                "datetime": 1788405998,
                "headline": "Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium"
              }
            ],
            "raw_source": [
              {
                "id": 142495990,
                "url": "https://finnhub.io/api/news?id=fd783d9531d6aea985a3f147cf94ae80e7fc927a2199f6843cae0a0b5759d2b9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year. One has raised its dividend for 54 consecutive years and still trades at a rare discount.",
                "category": "company",
                "datetime": 1790688410,
                "headline": "3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth"
              },
              {
                "id": 142496159,
                "url": "https://finnhub.io/api/news?id=83f71601a00f54a74e6598b61c5d123e4058c47aabeb722ac13ef83ef9197025",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 70 years of manufacturing in Sandy, Utah, a key part of the company's U.S. manufacturing network and a critical source of the medical technologies healthcare providers and patients depend on for daily care worldwide.",
                "category": "company",
                "datetime": 1790686800,
                "headline": "BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy"
              },
              {
                "id": 142470210,
                "url": "https://finnhub.io/api/news?id=1eb8fcec8e4958ff4b4fc4f435a8735d9886aafb4da564a75f8426e062cd604b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback occurred in September, when the company said a cyberattack would likely keep it from meeting its guidance. If the wider market turns now, how big could the next fall be, and how long would you wait? The answer depends on how well Boston Scientific is equipped to absorb a broader downturn today.",
                "category": "company",
                "datetime": 1790622564,
                "headline": "How Big Could BSX Stock's Next Fall Be?"
              },
              {
                "id": 142469358,
                "url": "https://finnhub.io/api/news?id=df6606a47f06bf41c262e3c74d80e5e1a9270c0e6b943a74aeee5a7d769eac3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson's MedTech transformation, innovation pipeline and strategic partnerships support growth despite reimbursement and macroeconomic pressures.",
                "category": "company",
                "datetime": 1790608500,
                "headline": "Here's Why You Should Retain BDX Stock in Your Portfolio for Now"
              },
              {
                "id": 142453159,
                "url": "https://finnhub.io/api/news?id=a858de7c4755f727def1d938c4a395431e61d53c9193adecc8cfe68e25951e21",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260312486/image_2260312486.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.",
                "category": "company",
                "datetime": 1790556963,
                "headline": "Best Dividend Aristocrats For October 2026"
              },
              {
                "id": 142440744,
                "url": "https://finnhub.io/api/news?id=771ab5791f4683b9c7832a0cf6f600113cb03205f449c47ef897f027336367c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses. Speaking at a JPMo",
                "category": "company",
                "datetime": 1790456523,
                "headline": "Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum"
              },
              {
                "id": 142436404,
                "url": "https://finnhub.io/api/news?id=a4f92bd1831f5e2f976ab0483dbf881e406ba812d7f17d2da0bb27b125a0344b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253044633/image_2253044633.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain.",
                "category": "company",
                "datetime": 1790408706,
                "headline": "Best Dividend Kings: September 2026"
              },
              {
                "id": 142432371,
                "url": "https://finnhub.io/api/news?id=403589f5a28b768b40e6b9e54ab5a5d2aa8836e772aecee6e6c1fa8830560d81",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1790377479,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 27"
              },
              {
                "id": 142374479,
                "url": "https://finnhub.io/api/news?id=2274026271691a6bca056c33e79b5fdba12d39f0a06b06cddf57c2f4d1c77582",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The global smoke evacuation systems market is forecast to grow from USD 0.20 billion in 2025 to USD 0.30 billion by 2031, at a 7.5% CAGR. Growth is driven by rising minimally invasive, electrosurgical and laparoscopic procedures, stricter surgical smoke safety guidance, and demand for better operating room air quality. Smoke evacuation pencils and wands lead the product segment, while laparoscopic surgery holds the largest application share. The US is expected to record North America’s fastest g",
                "category": "company",
                "datetime": 1790245440,
                "headline": "Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson"
              },
              {
                "id": 142363368,
                "url": "https://finnhub.io/api/news?id=3e54759dd8681c624ddc055f5cbfeb9fd60dd8eb3a6e51aa0272e0b662a74521",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2235272368/image_2235272368.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Waters has rebounded sharply, with shares rising from $300 to $425 on solid organic and acquired sales growth. Click to read more about the WAT stock here.",
                "category": "company",
                "datetime": 1790172220,
                "headline": "Waters: Positive Momentum Rides High Again"
              },
              {
                "id": 142337703,
                "url": "https://finnhub.io/api/news?id=a1516005ecda3c0e8ae450966ffc28c5ba1107101160222ee74db8d7407f54ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a share. That band is wide, but it is close to how much the stock has already been moving.",
                "category": "company",
                "datetime": 1790083789,
                "headline": "How Far Can BSX Stock Swing After Losing More Than Half Its Value?"
              },
              {
                "id": 142315609,
                "url": "https://finnhub.io/api/news?id=dcc77e154faef385ea585772f5979ccd3703c68bb5519177280c960790d215a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30.",
                "category": "company",
                "datetime": 1790022600,
                "headline": "Arthur Hu to Join BD as Chief Information and Digital Officer"
              },
              {
                "id": 142286417,
                "url": "https://finnhub.io/api/news?id=5dd23fe5e9615e5e1fac99a81dbb5a829ca077e995eccd08c53bbbeafd528560",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (NYSE:BDX) reached an SEC cease and desist settlement over past Alaris infusion pump risk disclosures, including a civil penalty and creation of a Fair Fund for investors. Subsidiary C.R. Bard recently faced a plaintiff verdict in Bard PowerPort litigation, with thousands of related product liability cases still pending. The Alaris disclosure settlement and Bard PowerPort verdict both tie into a wider pattern of legal and compliance pressures our research tracks. We have...",
                "category": "company",
                "datetime": 1789898962,
                "headline": "Why Is Becton Dickinson (BDX) Facing Fresh SEC And Litigation Pressure?"
              },
              {
                "id": 142262612,
                "url": "https://finnhub.io/api/news?id=9156ecf7e86c027bc888c338607f18b47e365681f01ac12302bef887f39a6413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]",
                "category": "company",
                "datetime": 1789773304,
                "headline": "Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?"
              },
              {
                "id": 142253583,
                "url": "https://finnhub.io/api/news?id=8356bac81b787ef1c8c2563fd1a0271c3a89e7f23b26f70675040b8e00a1ed71",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1492205944/image_1492205944.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges.",
                "category": "company",
                "datetime": 1789719371,
                "headline": "The Dividend Kings Ranked By Quality Scores (September 2026)"
              },
              {
                "id": 142232567,
                "url": "https://finnhub.io/api/news?id=bf01c78c5413fc07eccd6e35b784d8399ca9e765109e0ef302ff11757f2ef5c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Boston Scientific (BSX) has fallen about 54% since late December 2025, and it now sits at $43.91, just above a 52-week low of $42.63. Device peers were mixed over the same nine months: Abbott lost about 17%, Medtronic barely moved, and Johnson & Johnson rose about 32%. The market repriced Boston Scientific's growth rate after management concentrated its guidance cut in two core product lines.",
                "category": "company",
                "datetime": 1789662685,
                "headline": "Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising"
              },
              {
                "id": 142168486,
                "url": "https://finnhub.io/api/news?id=c044a6e1d52e39cde6fc1ad7235e9bc9a941eeb5c6fc1264664d76af8a716410",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Boston Scientific (BSX) stock has fallen about 57% over the past year, to about $45. The shares now sell for 3.2 times trailing sales, hovering near their decade-long historical trough of roughly 3.0 times and well off their 8.6 high.",
                "category": "company",
                "datetime": 1789498857,
                "headline": "Has BSX Stock Finally Hit Bottom?"
              },
              {
                "id": 142166116,
                "url": "https://finnhub.io/api/news?id=9d096852b479a00d578130a812ade2f1359c9aa90af267750b8fd8fcff2a960a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.",
                "category": "company",
                "datetime": 1789485660,
                "headline": "BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation"
              },
              {
                "id": 142136487,
                "url": "https://finnhub.io/api/news?id=0becd5b9f7f7a64a068e3e60fa05968423494a19e72785e847b1aa6450026a1d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Fairview Health Services has become the first health system in the United States to deploy the BD Vmax 160, a next generation pharmacy automation robot designed to help health systems manage the increasing complexity of specialty therapies and refrigerated medicines in high-volume, centralized outpatient pharmacy operations.",
                "category": "company",
                "datetime": 1789383000,
                "headline": "BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview"
              },
              {
                "id": 142028634,
                "url": "https://finnhub.io/api/news?id=80e7de8999e6a41acd61752ba4a09ba315b534d097c582121d26f62ef8d54a24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak.  Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point.  Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.",
                "category": "company",
                "datetime": 1788977210,
                "headline": "BSX Stock: Is It Time To Buy Or Sell Puts?"
              },
              {
                "id": 142027197,
                "url": "https://finnhub.io/api/news?id=7fd23c787c97bfe50fed26561c991b2395d3536d42df1fb0c06d8a96ee37815e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Becton, Dickinson and Company (BDX) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsThomas Polen - President,...",
                "category": "company",
                "datetime": 1788961637,
                "headline": "Becton, Dickinson and Company (BDX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 142020706,
                "url": "https://finnhub.io/api/news?id=98087cf4336dff9b3f4e3b4d9f3663b0df0517898edbd958d7728bb9da1728ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson & Co (NYSE:BDX) recently announced a total dividend of $1.05 per share, with the ex-dividend date set for 2026-09-09.  This cash dividend is payable on 2026-09-30.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.",
                "category": "company",
                "datetime": 1788951690,
                "headline": "Becton Dickinson & Co's Dividend Analysis"
              },
              {
                "id": 141769004,
                "url": "https://finnhub.io/api/news?id=8a8af4f0e29e2e47735ebf112f4099a3ab5bb4698e572bde01e1576f55be9137",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.",
                "category": "company",
                "datetime": 1788809880,
                "headline": "BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure"
              },
              {
                "id": 141485601,
                "url": "https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1788562641,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 6"
              },
              {
                "id": 141455029,
                "url": "https://finnhub.io/api/news?id=9980113490b89d23a66c8ffb6cd96ecfaacbd42b6a644618293f4755fb4708bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.",
                "category": "company",
                "datetime": 1788546339,
                "headline": "How Much Upside Can BSX Stock's Growth Deliver?"
              },
              {
                "id": 141464852,
                "url": "https://finnhub.io/api/news?id=50046c000a5f25411b9f89fce4ff5775ed5cfc999a09d0f0e5a698fa7805464f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson and Company has notably outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1788534513,
                "headline": "How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks?"
              },
              {
                "id": 141394944,
                "url": "https://finnhub.io/api/news?id=1f2d90bf76cdf9483bf09b320f85ea31b0881537420c526b48fe2815dd22eb5b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (NYSE:BDX) has become a founding sponsor of a new Medicinal Hazard Data Standardization Consortium focused on hazardous drug information. The global initiative aims to create standardized Medicinal Hazard Data Sheets to reduce data fragmentation and support safer handling of hazardous medicines for healthcare workers. Several major healthcare companies are joining BD in the consortium, which is expected to influence future regulatory and clinical best practice...",
                "category": "company",
                "datetime": 1788405998,
                "headline": "Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium"
              },
              {
                "id": 141379530,
                "url": "https://finnhub.io/api/news?id=de9681a0ee09a77cf542eab958e12b5cad3038528e2ac5c18cac277bcda9770e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The market's valuation reflects a wide breadth of potential outcomes for the company, exposing shareholders to the full magnitude of that underlying risk.",
                "category": "company",
                "datetime": 1788375156,
                "headline": "The Wide Divide Priced Into Boston Scientific Stock"
              },
              {
                "id": 141360880,
                "url": "https://finnhub.io/api/news?id=9f26bd8922432f5a0314cbcbab75d980716eaa1f1418c04dae1e6c70cefd2ab9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "This medical device maker posts elite numbers but wears a bargain-bin price tag, and the reason is a sudden crisis of confidence in its star products.",
                "category": "company",
                "datetime": 1788227277,
                "headline": "The Peer-Group Mispricing Sitting On BSX Stock"
              },
              {
                "id": 141360870,
                "url": "https://finnhub.io/api/news?id=3940eba2f9e552a33646a0657cfce9c2e5a582261d24899fe708d82efeab8c82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns. Here are the four names that made it happen and whether their income streaks can survive what comes next.",
                "category": "company",
                "datetime": 1788195506,
                "headline": "Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends"
              },
              {
                "id": 141363785,
                "url": "https://finnhub.io/api/news?id=52a212ee258f5c9d57aa79de1171a3e3e1c53086a47c9d6dea706f68d5ead932",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The funding answers a documented gap. Hazardous drug classification remains fragmented across the NIOSH list, USP General Chapter <800>, ISOPP standards and European directives - frameworks that diverge in scope, definition and enforceability.",
                "category": "company",
                "datetime": 1788194700,
                "headline": "Four Industry Sponsors Commit $100,000 to Launch the Medicinal Hazard Data Standardization Consortium"
              },
              {
                "id": 141360981,
                "url": "https://finnhub.io/api/news?id=7d5f22cbef8e157ea1ba869d201eb992d906f5ee88dcf71ac0c3a75b51a38721",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Jim Cramer just put a Brazilian mining giant in the same sentence as cryptocurrency, and his reasoning has everything to do with where he thinks inflation is headed next.",
                "category": "company",
                "datetime": 1788191425,
                "headline": "Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”"
              },
              {
                "id": 141356087,
                "url": "https://finnhub.io/api/news?id=fdddf9d19eeb7556232b1d51c414a8c6fc8c2694dfd1ae7bff42c10e2cd63df0",
                "image": "",
                "source": "Benzinga",
                "related": "BDX",
                "summary": "B of A Securities  analyst Travis Steed   maintains Becton Dickinson (NYSE:BDX) with a Neutral and raises the price target from $185 to $200.",
                "category": "company",
                "datetime": 1788183564,
                "headline": "B of A Securities Maintains Neutral on Becton Dickinson, Raises Price Target to $200"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.5,
            "source_article_count": 33,
            "discarded_article_count": 28
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.1,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日4日)；靠近20日高位；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1794826.6666666667,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 2022490,
              "avg_vol_20": 1798415,
              "avg_vol_30": 1794826.6666666667,
              "range_pct_10": 0.04692737430167601,
              "range_pct_20": 0.09251391061452513,
              "range_pct_30": 0.0998324413407822,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1268441892253291,
              "dist_to_20d_high": 0.06654146154262935,
              "down_shrink_days": 4,
              "breakout_level_20d": 191.75999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4700613715484275
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.131284916201117,
              "turnoverUsdM": 320.09496,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.BDX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 171.37,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.3,
            "take_profit_price": 187.95,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.262569832402234,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 3.815,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.13
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -61.81
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0851
    },
    "kdj": {
      "d": 50.3,
      "j": 33.85,
      "k": 44.81,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 40.9
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 3850260,
      "recentSlope": -881434,
      "previousSlope": -48080
    },
    "rsi": 54.27,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 186.63,
      "position": "SAR喺價上",
      "distancePct": 4.26,
      "previousTrend": "上升"
    },
    "ma50": 179.1188,
    "macd": {
      "macd": 0.3427154087598012,
      "trend": "中性偏多",
      "signal": 0.9105248825139561,
      "histogram": -0.5678094737541549
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 181.8734,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.98,
      "score": 4,
      "avgVolume": 1823842,
      "currentVolume": 1788240
    },
    "derived": {
      "ma20": 182.006,
      "ma50": 179.1188,
      "prevClose": 181.97,
      "avgVolume10": 2027914,
      "avgVolume20": 1823842,
      "changePercent": -1.63,
      "avgVolumeForScore": 1823842
    },
    "ma_cross": {
      "ma20": 182.006,
      "ma50": 179.1188,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 182.412,
      "prevMa50": 178.6156,
      "spreadPct": 1.61,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 176.0867,
      "upper": 187.9253,
      "position": "中間"
    },
    "rsi_short": 34.85,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.98
    }
  }
}

{
  "close": 179,
  "volume": 1788240,
  "changePercent": -1.63
}